Permira to sell I-Med to Jardine Matheson: AFR

Permira, the London-based private equity firm, has entered into an agreement to sell its stake in I-Med Radiology to Jardine Matheson, a Hong Kong-listed conglomerate, according to the Australian Financial Review [引用越界:1]. The transaction marks a significant shift in ownership for the diagnostic imaging provider, which operates more than 200 imaging centers across Australia.

I-Med was acquired by Permira in 2019 as part of a broader strategy to consolidate the fragmented radiology market. Since then, the company has expanded its footprint and enhanced its digital capabilities, including adoption of artificial intelligence in diagnostic imaging.

Jardine Matheson, which has a long-standing presence in Australia through its subsidiaries, is expected to integrate I-Med into its broader healthcare portfolio. The deal is subject to regulatory approvals and is anticipated to close in the coming months.

The transaction reflects ongoing investor interest in the healthcare sector, particularly in asset-backed services with stable cash flows. Analysts suggest that the sale aligns with Permira’s strategy to exit mature investments and redeploy capital into emerging opportunities.